Company Filing History:
1 out of 1,748 
1 out of 5,104 
1 out of 57 
Years Active: 2020
Title: Rémi Porte: Innovator in Pharmaceutical Treatments
Introduction
Rémi Porte is a notable inventor based in Lille, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial superinfections following influenza. His innovative approach has the potential to improve patient outcomes in critical healthcare scenarios.
Latest Patents
Rémi Porte holds 1 patent for his invention titled "Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza." This patent focuses on methods and pharmaceutical compositions that involve administering a therapeutically effective amount of a flagellin polypeptide, optionally in combination with at least one antibiotic, to treat bacterial superinfections in subjects recovering from influenza.
Career Highlights
Throughout his career, Rémi Porte has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Rémi Porte has collaborated with notable colleagues, including Jean-Claude Sirard and Christophe Carnoy. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
Rémi Porte's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through research and invention. His work in treating bacterial superinfections post-influenza is a testament to his expertise and dedication to advancing medical science.